A Phase IV, Randomized, Open-label Study of the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 11 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2009 Results have been presented at IAS 2009.
- 20 Feb 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History